Schisandrin B Prevents Doxorubicin-Induced Chronic Cardiotoxicity and Enhances Its Anticancer Activity In Vivo

BACKGROUND: To mitigate the cardiotoxicity of anthracycline antibiotics without compromising their anticancer activities is still an issue to be solved. We previously demonstrated that schisandrin B (Sch B) could protect against doxorubicin (Dox)-induced acute cardiotoxicity via enhancing cardiomyoc...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Yang, Liu, Zhen, Sun, Jie, Pan, Qiangrong, Sun, Feifei, Yan, Zhiyu, Hu, Xun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2011
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3229562/
https://www.ncbi.nlm.nih.gov/pubmed/22164272
http://dx.doi.org/10.1371/journal.pone.0028335

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3229562/
https://www.ncbi.nlm.nih.gov/pubmed/22164272
http://dx.doi.org/10.1371/journal.pone.0028335

Ejemplares similares